Literature DB >> 15232492

cDNA microarrays reveal distinct gene expression clusters in idiopathic inflammatory myopathies.

Xiaodong Zhou1, Mazen M Dimachkie, Momiao Xiong, Filemon K Tan, Frank C Arnett.   

Abstract

BACKGROUND: Polymyositis (PM) and dermatomyositis (DM) are complex human diseases of autoimmune origin which cause progressive skeletal muscle weakness in adults and children. Histopathological studies of affected muscles suggest that cytotoxic T cell-induced injury predominates in PM, while humoral immune mechanisms seem more likely in DM. Early expression of MHC class I molecules on myocytes is a striking feature of both disorders. This study was to use gene microarray analysis of muscle biopsies from PM and DM patients to obtain a comprehensive view of molecules participating in disease pathogenesis. MATERIAL/
METHODS: Muscle biopsies from 10 patients (6 PM and 4 DM) and 5 controls were selected for gene expression profiles. Microarray filters containing 4000 known human genes were used to hybridize with RNAs from muscle biopsies. Real-time RT-PCR assays were used to confirmed selected genes that showed changes in expression levels in PM and DM from microarray data. The t-statistic was used to measure any differences in the amount of gene expression in the normal versus myositis biopsies.
RESULTS: Forty genes clustering into two major groups showed significantly altered expression levels in PM/DM compared to normal biopsies. One cluster of over-expressed genes was primarily of immune origin and included HLA-class I and II, interferon-inducible proteins, natural killer (NK) protein, immunoglobulins and complement. The other cluster of under-expressed genes were of muscle origin, especially those involved in the fast twitch response. PM and DM gene profiles appeared similar.
CONCLUSIONS: PM and DM muscle biopsies show similar gene expression profiles despite reported differences in histopathological changes. Altered gene expressions of immune regulation and myofibrillar proteins are prominent in muscle biopsies of myositis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15232492

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  16 in total

1.  An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity.

Authors:  Emily C Baechler; Jason W Bauer; Catherine A Slattery; Ward A Ortmann; Karl J Espe; Jill Novitzke; Steven R Ytterberg; Peter K Gregersen; Timothy W Behrens; Ann M Reed
Journal:  Mol Med       Date:  2007 Jan-Feb       Impact factor: 6.354

2.  Mycophenolate mofetil: a possible therapeutic agent for children with juvenile dermatomyositis.

Authors:  Kelly A Rouster-Stevens; Gabrielle A Morgan; Deli Wang; Lauren M Pachman
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-10       Impact factor: 4.794

3.  MxA gene expression in juvenile dermatomyositis peripheral blood mononuclear cells: association with muscle involvement.

Authors:  Kevin A O'Connor; Kathy A Abbott; Brad Sabin; Maxine Kuroda; Lauren M Pachman
Journal:  Clin Immunol       Date:  2006-07-21       Impact factor: 3.969

4.  Comparative gene expression profiling between human cultured myotubes and skeletal muscle tissue.

Authors:  Frederic Raymond; Sylviane Métairon; Martin Kussmann; Jaume Colomer; Andres Nascimento; Emma Mormeneo; Cèlia García-Martínez; Anna M Gómez-Foix
Journal:  BMC Genomics       Date:  2010-02-22       Impact factor: 3.969

5.  Changes in novel biomarkers of disease activity in juvenile and adult dermatomyositis are sensitive biomarkers of disease course.

Authors:  Ann M Reed; Erik Peterson; Hatice Bilgic; Steven R Ytterberg; Shreyasee Amin; Molly S Hein; Cynthia S Crowson; Floranne Ernste; Emily Baechler Gillespie
Journal:  Arthritis Rheum       Date:  2012-12

Review 6.  Idiopathic inflammatory myopathies.

Authors:  Mazen M Dimachkie; Richard J Barohn; Anthony A Amato
Journal:  Neurol Clin       Date:  2014-08       Impact factor: 3.806

7.  Sarcolipin and ubiquitin carboxy-terminal hydrolase 1 mRNAs are over-expressed in skeletal muscles of alpha-tocopherol deficient mice.

Authors:  Vihas T Vasu; Sean Ott; Brad Hobson; Vania Rashidi; Saji Oommen; Carroll E Cross; Kishorchandra Gohil
Journal:  Free Radic Res       Date:  2009-02

Review 8.  The type I interferons: Basic concepts and clinical relevance in immune-mediated inflammatory diseases.

Authors:  Consuelo M López de Padilla; Timothy B Niewold
Journal:  Gene       Date:  2015-09-26       Impact factor: 3.688

Review 9.  Idiopathic inflammatory myopathies.

Authors:  Mazen M Dimachkie; Richard J Barohn
Journal:  Semin Neurol       Date:  2012-11-01       Impact factor: 3.420

10.  Gene expression profiles from discordant monozygotic twins suggest that molecular pathways are shared among multiple systemic autoimmune diseases.

Authors:  Terrance P O'Hanlon; Lisa G Rider; Lu Gan; Rick Fannin; Richard S Paules; David M Umbach; Clarice R Weinberg; Ruchir R Shah; Deepak Mav; Mark F Gourley; Frederick W Miller
Journal:  Arthritis Res Ther       Date:  2011-04-26       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.